Live feed
Filing
SCHEDULE 13G
SCHEDULE 13G0001415889-25-015080·DePinho Ronald A
Schedule 13G ownership disclosure
CARA THERAPEUTICS INC
Common Stock, par value $0.001 per share · CUSIP: 140755208
Event date: 2025-04-15
- Filing-level shares
- 780,990.00
- Percent of class
- 8.3%
- Ronald A. DePinho
Shares: 780,990.00 · Class: 8.3%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001415889-25-015080
- Form type
- SCHEDULE 13G
- Filer
- DePinho Ronald A
- CIK
- CIK 1486420
- Filed
- Jun 02, 2025
- Reporting period
- Apr 15, 2025
- Description
- Schedule 13G beneficial ownership